<DOC>
	<DOCNO>NCT02692313</DOCNO>
	<brief_summary>Epinephrine principal physiologic defense hypoglycemia type 1 long duration type 2 DM . Despite , unknown epinephrine regulate in-vivo endothelial function atherothrombotic balance human . The specific aim study determine dose response effect key ANS counterregulatory hormone epinephrine endothelial function , fibrinolytic balance pro-atherogenic inflammatory mechanism healthy human .</brief_summary>
	<brief_title>Dose Response Epinephrine</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Complications</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>healthy control age 1855 yr . Body mass index &gt; 21 kg Â· m2 Pregnant breastfeed woman Subjects unwilling unable comply approve contraception measure Subjects unable give voluntary inform consent Subjects anticoagulant drug , anemic know bleeding diatheses Subjects history severe , uncontrolled hypertension , heart disease , cerebrovascular incident Current tobacco use Subjects know allergy study medication use Physical Exam Exclusion Criteria Uncontrolled severe hypertension ( i.e. , blood pressure great 160/100 ) Clinically significant cardiac abnormality ( e.g . heart failure , arrhythmia ) Pneumonia treatment hospitalization within 2 week prior enrollment ( study visit ) Hepatic failure / jaundice Renal failure Cerebrovascular accident occurrence hospitalization within 4 week prior enrollment Fever great 38.0 degree C Screening Laboratory Tests Exclusion Criteria Hematocrit low 32 % White blood cell ( WBC ) count low 3 thou/ul great 14 thou/ul Liver function test : serum glutamic oxaloacetic transaminase ( SGOT ) serum glutamicpyruvic transaminase ( SGPT ) great twice upper limit normal range Alkaline phosphatase great 150U/L Total bilirubin ( TBil ) great 2 mg/dl Estimated glomerular filtration rate ( eGFR ) less 60 mL/min/1.73 m2 Positive human immunodeficiency virus ( HIV ) , Hepatitis B Hepatitis C Any abnormal cardiac response multistage exercise test ( 40 year age )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>epinephrine</keyword>
	<keyword>counterregulation</keyword>
	<keyword>dose response</keyword>
</DOC>